Drug reference
tirbanibulin
Mitotic inhibitor · Antineoplastic
Mitotic inhibitorAntineoplastic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Tirbanibulin is a mitotic inhibitor that binds to the colchicine binding site on β-tubulin.
Indications
Local treatment of actinic keratosis
Related guidelines
Ask House about tirbanibulin
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team